Related Experiment Video
Updated: May 8, 2026

Three-dimensional Confocal Analysis of Microglia/macrophage Markers of Polarization in Experimental Brain Injury
Published on: September 4, 2013
Upregulation of TRPC1 in microglia promotes neutrophil infiltration after ischemic stroke
Hao Qian1, Hui-Nan Zhang2, Tian Gao2
1Health Management Center, Second Affiliated Hospital, Fourth Military Medical University, Xi'an 710038, China; Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, China.
Abstract:
Neutrophil infiltration has been linked to worse clinical outcomes after ischemic stroke. Microglia, a key type of immune-competent cell, engage in cross-talk with the infiltrating immune cells in the inflamed brain area, yet the molecular mechanisms involved remain largely unexplored. In this study, we investigated the mechanisms of how canonical transient receptor potential 1 (TRPC1) modulated neutrophil infiltration in male mouse cerebral ischemia and reperfusion injury (CIRI) models. Our findings revealed a notable upregulation of TRPC1 in microglia within both middle cerebral artery occlusion reperfusion (MCAO/R) and in vitro oxygen-glucose deprivation/regeneration (OGD/R) model. Conditional Trpc1 knockdown in microglia markedly reduced infarct volumes and alleviated neurological deficits. Microglia conditional Trpc1 knockdown mice displayed less neutrophil infiltration in peri-infarct area. Trpc1 knockdown microglia exhibited a reduced primed proinflammatory phenotype with less secretion of CC-Chemokines ligand (CCL) 5 and CCL2 after MCAO/R. Blocking CCL5/2 significantly mitigated neutrophil infiltration in microglia/neutrophil transwell co-culture system upon OGD/R condition. Trpc1 knockdown markedly reduced store-operated calcium entry and nuclear factor of activated T-cells c1 (NFATc1) level in OGD/R treated microglia. Overexpression of Nfatc1 reversed the CCL5/2 reducing effect of Trpc1 knockdown, which is mediated by small interfering RNA in BV2 cells upon OGD/R. Our data indicate that upregulation of TRPC1 in microglia stimulates the production of CCL5/2 through the Ca2+/NFATc1 pathway. Upregulated CCL5/2 leads to an increase in neutrophil infiltration into the brain, thereby aggravating reperfusion injury. Our results demonstrate the importance of TRPC1 in microglia-mediated neuroinflammation and suggest a potential means for reducing CIRI induced neurological injury.
Insights
Canonical transient receptor potential 1 (TRPC1) in microglia drives neutrophil infiltration and worsens stroke injury. Reducing TRPC1 in microglia lessens brain damage and inflammation, offering a potential therapeutic target for cerebral ischemia and reperfusion injury.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Neutrophil infiltration correlates with poor outcomes in ischemic stroke.
- Microglia-immune cell interactions in brain inflammation are not fully understood.
Purpose of the Study:
- Investigate the role of canonical transient receptor potential 1 (TRPC1) in microglia-mediated neutrophil infiltration during cerebral ischemia and reperfusion injury (CIRI).
Main Methods:
- Utilized male mouse models of middle cerebral artery occlusion/reperfusion (MCAO/R) and in vitro oxygen-glucose deprivation/regeneration (OGD/R).
- Examined TRPC1 expression in microglia and employed conditional Trpc1 knockdown in microglia.
- Assessed infarct volume, neurological deficits, neutrophil infiltration, CC-chemokine ligand (CCL) 5 and CCL2 secretion, store-operated calcium entry, and nuclear factor of activated T-cells c1 (NFATc1) levels.
Main Results:
- TRPC1 was upregulated in microglia during MCAO/R and OGD/R.
- Conditional Trpc1 knockdown in microglia reduced infarct size, neurological deficits, and neutrophil infiltration.
- Trpc1 knockdown decreased CCL5 and CCL2 secretion from microglia, mitigating neutrophil infiltration.
- TRPC1 modulated Ca2+ entry and NFATc1 activation in microglia, linking TRPC1 to CCL5/2 production.
Conclusions:
- TRPC1 in microglia promotes neutrophil infiltration via the Ca2+/NFATc1 pathway, increasing CCL5/2 production and exacerbating CIRI.
- Targeting TRPC1 in microglia presents a potential therapeutic strategy for reducing neurological damage in stroke.

